CAM
PCVX icon

ClariVest Asset Management’s Vaxcyte PCVX Stock Holding History

ClariVest Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$313K Hold
4,140
– – 0.03% 368
2024
Q2 		$313K Sell
4,140
-8
-0.2% -$545 0.03% 368
2024
Q1 		$283K Buy
+4,148
New +$287K 0.03% 370

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClariVest Asset Management's PCVX Position: Q3 2024 in Review

ClariVest Asset Management held its Vaxcyte (PCVX) position steady in Q3 2024 at 4,140 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #368.

ClariVest Asset Management first reported a position in PCVX in Q1 2024 and has held it in 3 quarters since. 328 funds tracked by Wall St. Rank hold PCVX as of Q3 2024.

  • ClariVest Asset Management held 4,140 shares of Vaxcyte worth $313K as of Q3 2024.
  • ClariVest Asset Management left its Vaxcyte share count unchanged in Q3 2024.
  • Vaxcyte made up 0.03% of ClariVest Asset Management's portfolio in Q3 2024, its #368 holding.
  • ClariVest Asset Management first reported a position in Vaxcyte in Q1 2024 and has held it in 3 quarters since.
  • 328 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.